[Table/Fig-1]:
Clinical signs and symptoms | Stage 1 (of 119) | Stage 2 (of 39) | Stage 3 (of 11) | Stage 4 (of 11) | p-value | ||||
---|---|---|---|---|---|---|---|---|---|
N(%) | OR | N(%) | OR | N(%) | OR | N(%) | OR | ||
Menstrual Irregularity | 25 (21.00%) | 1.00 | 4 (10.25%) | 0.43 | 1 (9.09%) | 0.38 | 2 (18.18%) | 0.84 | 0.40 (NS) |
Heavy Menstrual flow | 12 (10.08%) | 1.00 | 5 (12.82%) | 1.31 | 2 (18.18%) | 1.98 | 3 (27.27%) | 3.34 | 0.36 (NS) |
Scant Menstrual flow | 6 (5.04%) | 1.00 | 3 (7.69%) | 1.57 | 2 (18.18%) | 4.19 | 1 (9.09%) | 1.97 | 0.39 (NS) |
Dysmenorrhea | 40 (33.61%) | 1.00 | 23 (58.97%) | 2.83 | 6 (54.54%) | 2.37 | 7 (63.63) | 3.45 | 0.01 * |
Dyspareunia | 5 (4.20%) | 1.00 | 4 (10.25%) | 2.61 | 3 (27.27%) | 8.55 | 5 (45.45%) | 19 | <0.01 * |
Chronic Pelvic pain | 1 (0.84%) | 1.00 | 1 (2.56%) | 3.11 | 1 (9.09%) | 11.8 | 5 (45.45%) | 98.33 | <0.01 * |
Abdominal mass | 0 (0.00%) | 1.00 | 0 (0.00%) | N/A | 0 (0.00%) | N/A | 0 (0.00%) | N/A | - |
Tenderness | 4 (3.36%) | 1.00 | 4 (10.25%) | 3.29 | 6 (54.54%) | 34.5 | 11 (100%) | N/A | <0.01 * |
Adnexal mass | 1 (0.84%) | 1.00 | 0 (0.00%) | N/A | 2 (18.18%) | 26.22 | 6 (54.54%) | 141.6 | <0.01 * |
Restricted Mobility | 1 (0.84%) | 1.00 | 3 (7.69%) | 9.83 | 4 (36.36%) | 67.42 | 10 (90.90%) | 1180 | <0.01 * |
(OR represents Odds Ratios. p <0.05 considered to be statistically significant difference Here, NS represents Non-Significant difference between these groups.)